Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials

Li Xuyuan; Zhu Sujuan; Hong Chaoqun; Cai Haoquan

首页> 外文期刊>Current medical research and opinion >Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials

【24h】

Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials

机译：卵巢癌患者血管生成抑制剂：12项随机对照试验的荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:

机译：目标：

著录项

来源
《Current medical research and opinion》 |2016年第3期|共8页
作者
Li Xuyuan; Zhu Sujuan; Hong Chaoqun; Cai Haoquan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Meta-analysis; Ovarian cancer; Toxicity; Angiogenesis;

机译：荟萃分析;卵巢癌;毒性;血管生成;
入库时间 2022-08-18 09:45:58

相似文献

外文文献
中文文献
专利

1. Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials [J] . Li Xuyuan, Zhu Sujuan, Hong Chaoqun, Current medical research and opinion . 2016,第3期

机译：卵巢癌患者血管生成抑制剂：12项随机对照试验的荟萃分析
2. Does the age affect the efficacy of angiogenesis inhibitors in ovarian cancer? A meta-analysis of randomized controlled trials [J] . H. Miao, C.-X. Miao, J. Han, European review for medical and pharmacological sciences. . 2017,第13期

机译：年龄会影响血管生成抑制剂在卵巢癌中的功效吗？随机对照试验的荟萃分析
3. Adverse events risk associated with angiogenesis inhibitors addition to therapy in ovarian cancer: a meta-analysis of randomized controlled trials [J] . Liang X. -J., Shen J. European review for medical and pharmacological sciences. . 2016,第12期

机译：卵巢癌治疗中与血管生成抑制剂相关的不良事件风险：一项随机对照试验的荟萃分析
4. Meta-Analysis of Randomized Controlled Trial in Treating Primary Liver Cancer by Fufang Kushen Injection Combined with TACE [C] . Dehui Li, Huanfang Fan, Chunxia Sun International Conference on Sustainable Energy and Environmental Engineering . 2016

机译：富芳九仁注射用TACE治疗原发性肝癌的随机对照试验的荟萃分析
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials [O] . Fengping Shao, Jun Liu, Yaoyun Duan, 2020

机译：PARP抑制剂作为卵巢癌维持疗法的功效和安全性：九项随机对照试验的荟萃分析
7. The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials [O] . Rong-Hua Tian, Xia Wu, Xia Liu, 2016

机译：血管生成抑制剂在老年晚期非小细胞肺癌患者治疗中的作用：11项随机对照试验的荟萃分析

Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials

摘要

著录项

相似文献

相关主题

期刊订阅